Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized Phase 3 study of miconazole 2% + fluprednidene 0.1% cream vs Vobaderm Cream vs vehicle in moderate to severely inflamed cutaneous candidiasis
2019-001010-42Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of miconazole + fluprednidene in cutaneous candidiasis and onychomycosis (3 arms), sponsored by Dermapharm. Primary endpoint: Treatment success at end of treatment. Started Jul 2019; status: completed.
02
Drugs
miconazole + fluprednidene
03
Conditions
cutaneous candidiasisonychomycosis
Beyond the preview
Go deeper on 2019-001010-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001010-42.